Modalities of use of oral propranolol in proliferative infantile haemangiomas: an international survey among practitioners.

Robert, J; Tavernier, E; Boccara, O; Mashiah, J; Mazereeuw-Hautier, J; Maruani, A

Robert, J; Tavernier, E; Boccara, O; Mashiah, J; Mazereeuw-Hautier, J; Maruani, A.

Afiliação

Robert J; CHRU Tours, Department of Dermatology, Unit of Pediatric Dermatology and Reference Center for Rare Diseases and Vascular Malformations (MAGEC), CHRU Tours, 37044, Tours CEDEX 9, France.
Tavernier E; Universities of Tours and Nantes, INSERM 1246 - SPHERE, 37000, Tours, France.
Boccara O; CHRU Tours, Clinical Investigation Center - INSERM 1415, 37044, Tours CEDEX 9, France.
Mashiah J; Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université Paris, Paris-Centre, Institut Imagine, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France.
Mazereeuw-Hautier J; Pediatric Dermatology Unit, Dana Children's Hospital, Department of Dermatology and Venereology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Maruani A; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Br J Dermatol ; 183(3): 573-575, 2020 09.

Article em En | MEDLINE | ID: mdl-32221977

Assuntos

Hemangioma; Neoplasias Cutâneas; Antagonistas Adrenérgicos beta; Hemangioma/tratamento farmacológico; Humanos; Lactente; Propranolol; Neoplasias Cutâneas/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Hemangioma Limite: Humans / Infant Idioma: En Revista: Br J Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google